Hair transplant surgery

In co-author lists, Merck researchers appear in italics.


Dow Stough, MD
The Stough Hair Center, Fayetteville, Arkansas

  • Finasteride Male Pattern Hair Loss Study Group
    • Investigator, Studies 047, 081, 087
  • Dutasteride Alopecia Research Team
  • Co-authors: Kaufman, Gormley, Rittmaster, Imperato-McGinley, Olsen, Price, Roberts, Shapiro, Washenik, Whiting
  • Papers

Ken Washenik, MD
Chief Medical Officer, Bosley Medical Group (network of hair restoration centers in the United States)
Clinical Assistant Professor, Department of Dermatology, NYU Grossman School of Medicine

  • Merck ties
    • Member, Finasteride Male Pattern Hair Loss Study Group
      • Investigator in Propecia clinical trials
    • Speakers Bureau member (source: presentation at 2017 CalDerm conference)
  • Papers
  • Co-authors: Olsen, Roberts, Shapiro, Stough, Whiting
  • Presentations
    • Presentation at 2017 CalDerm conference which addressed post-finasteride syndrome (view slides)
    • ‘Update on the post-finasteride controversy’ at the 10th World Congress for Hair Research in 2017 (view program)
    • ‘Is there a post-finasteride syndrome?’ at the 2019 World Congress of Dermatology (view summary in a Swiss dermatology newsletter, in German)
  • Professional activities: Member of the International Society for Hair Restoration Surgery (ISHRS)
  • Legal matters: Bosley Inc. and Bosley Medical Group (with Dr. Washenik as Chief Medical Officer) were defendants in Propecia Finasteride Product Liability Litigation (background)